Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily M Hawes

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Archives of Pathology & Laboratory Medicine|November 27, 2014
Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxabanRobert C Gosselin, Dorothy M Adcock Funk, J Michael Taylor, et al.
Thrombosis and Haemostasis|January 10, 2014
Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levelsSuzanne J Francart, Emily M Hawes, Allison M Deal, et al.
Biochimie|March 2, 2024
Biochemical and metabolic characterization of a G6PC2 inhibitorEmily M Hawes, Mohsin Rahim, Zeinab Haratipour, et al.
Diabetes|August 8, 2023
An Enhancer Within Abcb11 Regulates G6pc2 in C57BL/6 Mouse Pancreatic IsletsMark P Keller, Emily M Hawes, Kathryn L Schueler, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Archives of Pathology & Laboratory Medicine|November 27, 2014
Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxabanRobert C Gosselin, Dorothy M Adcock Funk, J Michael Taylor, et al.
Thrombosis and Haemostasis|January 10, 2014
Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levelsSuzanne J Francart, Emily M Hawes, Allison M Deal, et al.
Biochimie|March 2, 2024
Biochemical and metabolic characterization of a G6PC2 inhibitorEmily M Hawes, Mohsin Rahim, Zeinab Haratipour, et al.
Diabetes|August 8, 2023
An Enhancer Within Abcb11 Regulates G6pc2 in C57BL/6 Mouse Pancreatic IsletsMark P Keller, Emily M Hawes, Kathryn L Schueler, et al.
Pageof 6